Literature DB >> 26526902

Rapid acquisition axial and coronal T2 HASTE MR in the evaluation of acute abdominal pain.

Sam Byott1, Ian Harris2.   

Abstract

PURPOSE: To assess T2 HASTE MR in acute abdominal imaging and ascertain if it is a reliable alternative to CT in patients under 60. METHOD AND MATERIALS: In a prospective diagnostic performance study from January 2009 to December 2013, patients under 60 presenting with acute abdominal pain, that required imaging following surgical review, were imaged with T2 HASTE MR. Rapid acquisition HASTE (Half Fourier Acquisition Single Shot Turbo Spin Echo) coronal and axial sequences were obtained, without intravenous contrast. Patients were followed up clinically for a minimum of 3 months.
RESULTS: 468 cases included in the study. 349 were negative for acute abdominal pathology, 116 positive for acute abdominal pathology and 3 were indeterminate. In the MR positive group (n=116), 64 had surgery confirming findings (34 appendicitis, 14 SBO, 3 ovarian torsion, 3 LBO, intussusception, ovarian carcinoma, ovarian dermoid, 2 pelvic inflammatory disease, diverticular abscess, crohns, 4 endoscopy for acute bowel pathology) while 51 were managed conservatively with concordant follow up (4 SBO, 11 diverticulitis, 6 pelvic inflammatory disease, 7 inflammatory bowel disease, 7 colitis, 6 pyelonephritis, 2 cholecystitis, renal abscess, pseudomembranous colitis, splenic haematoma, mesenteric adenitis, 2 pancreatitis, lymphoma, epiploic appendagitis). 1 patient had an MR diagnosis of appendicitis but at laparoscopy a sigmoid diverticular perforation was diagnosed and the appendix was normal. In the MR negative group (n=349), 324 had uneventful follow-up, 22 had negative laparoscopies, while 3 had subsequent appendectomies, with appendicitis on histology (3 days, 10 days and 2 months post scan). In the MR indeterminate group (n=3), one was treated conservatively with uneventful follow up, one had laparoscopic appendectomy with normal appendix on histology, one had laparoscopic appendectomy with acute appendicitis on histology. When MR correlated with clinical follow up (n=468), overall diagnostic accuracy is 99% (463/468). When MR findings correlated with direct visualisation at surgery/endoscopy (n=90), sensitivity is 98% (95% CI) and specificity is 92% (95% CI).
CONCLUSION: This study demonstrates that rapid acquisition axial and coronal T2 HASTE MR is a practical, safe and effective method in the diagnosis of acute abdominal pain. MR is the preferred option to CT in patients of an age prone to radiation with a potential surgical diagnosis. CLINICAL RELEVANCE/APPLICATION: MRI in acute abdominal imaging is both effective and practical and is the preferred imaging option in patients of an age prone to radiation with a potential surgical diagnosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abdomen; Acute; Appendicitis; Emergency; HASTE; MRI

Mesh:

Year:  2015        PMID: 26526902     DOI: 10.1016/j.ejrad.2015.10.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  Comparative performance of non-contrast MRI with HASTE vs. contrast-enhanced MRI/3D-MRCP for possible choledocholithiasis in hospitalized patients.

Authors:  Stella K Kang; Laura Heacock; Ankur M Doshi; Justin R Ream; Jeffrey Sun; James S Babb
Journal:  Abdom Radiol (NY)       Date:  2017-06

Review 2.  Noncontrast MRI of acute abdominal pain caused by gastrointestinal lesions: indications, protocol, and image interpretation.

Authors:  Akitoshi Inoue; Akira Furukawa; Kai Takaki; Yugo Imai; Shinichi Ota; Norihisa Nitta; Yoshiyuki Watanabe
Journal:  Jpn J Radiol       Date:  2020-10-09       Impact factor: 2.374

Review 3.  Imaging in acute appendicitis: What, when, and why?

Authors:  Jyotindu Debnath; R A George; R Ravikumar
Journal:  Med J Armed Forces India       Date:  2016-03-29

4.  Value of high-field magnetic resonance imaging for diagnosis and classification of acute colonic diverticulitis.

Authors:  Markus Lurz; Angelos Gazis; Stefanie Hanschke; Arved Weimann; Arnd-Oliver Schäfer
Journal:  Int J Colorectal Dis       Date:  2021-10-11       Impact factor: 2.571

Review 5.  Magnetic resonance imaging (MRI) for diagnosis of acute appendicitis.

Authors:  Nigel D'Souza; Georgina Hicks; Richard Beable; Antony Higginson; Bo Rud
Journal:  Cochrane Database Syst Rev       Date:  2021-12-14

6.  Optimization of pulse sequences in ultrafast magnetic resonance imaging for the diagnosis of acute abdominal pain caused by gastrointestinal disease.

Authors:  Akitoshi Inoue; Akira Furukawa; Norihisa Nitta; Kai Takaki; Shinichi Ohta; Kiyoshi Murata
Journal:  Acta Radiol Open       Date:  2020-08-19

7.  The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery.

Authors:  Andrew S Miller; Kathryn Boyce; Benjamin Box; Matthew D Clarke; Sarah E Duff; Niamh M Foley; Richard J Guy; Lisa H Massey; George Ramsay; Dominic A J Slade; James A Stephenson; Phil J Tozer; Danette Wright
Journal:  Colorectal Dis       Date:  2021-02       Impact factor: 3.917

8.  MR Imaging-based Evaluation of Mesenteric Ischemia Caused by Strangulated Small Bowel Obstruction and Mesenteric Venous Occlusion: An Experimental Study Using Rabbits.

Authors:  Akitoshi Inoue; Norihisa Nitta; Shinichi Ota; Kai Takaki; Yugo Imai; Sayaka Misaki; Takayasu Iwai; Akinaga Sonoda; Ken-Ichi Mukaisho; Kiyoshi Murata
Journal:  Magn Reson Med Sci       Date:  2019-05-07       Impact factor: 2.471

9.  Role of CT Images in the Diagnosis of Common Acute Abdominal Diseases in General Surgery.

Authors:  Yunguang Nan; Zuyan Zhang; Jianbo Zhang; Bo Jiang; Yuxi Zhu; Li Zhang
Journal:  J Healthc Eng       Date:  2022-03-23       Impact factor: 2.682

10.  Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to 18F-FDG PET/CT.

Authors:  Dong Zheng; Yi Liu; Jiajin Liu; Ke Li; Mu Lin; Holger Schmidt; Baixuan Xu; Jiahe Tian
Journal:  Cancer Imaging       Date:  2020-06-16       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.